Form 4: Carlisle Companies Inc. Executive Receives Stock Options and Restricted Shares

Sentiment:

SEC Form 4 Filing


Susan Wallace, VP & CHRO of Carlisle Companies Inc., reports the acquisition of stock options and restricted shares on January 28, 2025.

Summary

  • On January 28, 2025, Susan Wallace, VP & CHRO of Carlisle Companies Inc. (CSL), acquired 280 restricted shares of common stock.
  • Wallace also acquired an option to purchase 965 shares of common stock at an exercise price of $395.46.
  • Following these transactions, Wallace directly owns 1,218 shares of common stock and options to purchase 965 shares.
  • The stock options vest in three equal annual installments beginning on January 28, 2026, and expire on January 27, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options and restricted shares is a common practice and suggests confidence in the company's future, but it doesn't provide specific details about financial performance.

Positives

  • The grant of restricted shares and stock options to a key executive suggests the company's confidence in its future performance.
  • The vesting schedule of the stock options incentivizes the executive to remain with the company for the long term.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the equity grants suggest an expectation of continued growth and value creation.

Industry Context

Executive compensation packages including stock options and restricted shares are common in publicly traded companies to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

  • Stock option grants are a typical component of executive compensation packages in publicly traded companies like Carlisle Companies Inc.
  • Comparable companies such as Honeywell, 3M, and Danaher also utilize stock options and restricted stock units to incentivize their executives.
  • The vesting schedule of three years is a standard practice to ensure executive retention and alignment with long-term company goals.

Stakeholder Impact

  • Shareholders: The equity grants align executive interests with shareholder value.
  • Employees: The grants can boost morale and incentivize performance.

Key Dates

DateDescription
01/28/2025Date of transaction: grant of restricted shares and stock options.
01/28/2026First vesting date for the employee stock options.
01/27/2035Expiration date for the employee stock options.
01/29/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.